Works matching IS 00070920 AND DT 2002 AND VI 87 AND IP 6

Results: 18

DNA topoisomerase I and II expression in drug resistantgerm cell tumours.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 624, doi. 10.1038/sj.bjc.6600472

By:

Berney, D M;
Shamash, J;
Gaffney, J;
Jordan, S;
Oliver, R T D

Publication type:

Article

Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 681

By:

Martínez, C;
García-Martín, E;
Pizarro, R M;
García-Gamito, F J;
Agúndez, J A G

Publication type:

Article

Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 615, doi. 10.1038/sj.bjc.6600514

By:

Bijker, N;
Peterse, J L;
Fentiman, I S;
Julien, J-P;
Hart, A A M;
Avril, A;
Cataliotti, L;
Rutgers, E J T

Publication type:

Article

Impact of deprivation and rural residence on treatment of colorectal and lung cancer.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 585, doi. 10.1038/sj.bjc.6600515

By:

Campbell, N C;
Elliott, A M;
Sharp, L;
Ritchie, L D;
Cassidy, J;
Little, J

Publication type:

Article

Heparanase is a prognostic indicator for postoperative survival in pancreatic carcinoma.

Published in:

2002

By:

Rohloff, J;
Zinke, J;
Schoppmeyer, K;
Tannapfel, A;
Witzigmann, H;
Mössner, J;
Wittekind, C;
Caca, K

Publication type:

Erratum

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 630, doi. 10.1038/sj.bjc.6600511

By:

Boulay, J-L;
Mild, G;
Lowy, A;
Reuter, J;
Lagrange, M;
Terracciano, L;
Laffer, U;
Herrmann, R;
Rochlitz, C

Publication type:

Article

Increased aquaporin 1 water channel expression inhuman brain tumours.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 621, doi. 10.1038/sj.bjc.6600512

By:

Saadoun, S;
Papadopoulos, M C;
Davies, D C;
Bell, B A;
Krishna, S

Publication type:

Article

Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 654, doi. 10.1038/sj.bjc.6600531

By:

Watters, A D;
Latif, Z;
Forsyth, A;
Dunn, I;
Underwood, M A;
Grigor, K M;
Bartlett, J M S

Publication type:

Article

Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 665, doi. 10.1038/sj.bjc.6600508

By:

van Hattum, A H;
Hoogsteen, I J;
Schlüper, H M M;
Maliepaard, M;
Scheffer, G L;
Scheper, R J;
Kohlhagen, G;
Pommier, Y;
Pinedo, H M;
Boven, E

Publication type:

Article

Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 635, doi. 10.1038/sj.bjc.6600510

By:

Fritz, G;
Brachetti, C;
Bahlmann, F;
Schmidt, M;
Kaina, B

Publication type:

Article

A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 600, doi. 10.1038/sj.bjc.6600517

By:

Francis, R J;
Sharma, S K;
Springer, C;
Green, A J;
Hope-Stone, L D;
Sena, L;
Martin, J;
Adamson, K L;
Robbins, A;
Gumbrell, L;
O'Malley, D;
Tsiompanou, E;
Shahbakhti, H;
Webley, S;
Hochhauser, D;
Hilson, A J;
Blakey, D;
Begent, R H J

Publication type:

Article

Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 673, doi. 10.1038/sj.bjc.6600518

By:

Kostourou, V;
Robinson, S P;
Cartwright, J E;
Whitley, G St J

Publication type:

Article

Secreted and tumour targeted human carboxylesterase for activation of irinotecan.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 659, doi. 10.1038/sj.bjc.6600519

By:

Oosterhoff, D;
Pinedo, H M;
van der Meulen, I H;
de Graaf, M;
Sone, T;
Kruyt, F A;
van Beusechem, V W;
Haisma, H J;
Gerritsen, W R

Publication type:

Article

Raltitrexed treatment promotes systemic inflammatory reaction in patients with colorectal carcinoma.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 591

By:

Österlund, P;
Orpana, A;
Elomaa, I;
Repo, H;
Joensuu, H

Publication type:

Article

A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 608, doi. 10.1038/sj.bjc.6600516

By:

Schoemaker, N E;
van Kesteren, C;
Rosing, H;
Jansen, S;
Swart, M;
Lieverst, J;
Fraier, D;
Breda, M;
Pellizzoni, C;
Spinelli, R;
Porro, M Grazia;
Beijnen, J H;
Schellens, J H M;
ten Bokkel Huinink, WW

Publication type:

Article

Oestrogen receptor beta: how should we measure this?

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 687, doi. 10.1038/sj.bjc.6600534

By:

Speirs, V;
Carder, P J;
Lansdown, M R J

Publication type:

Article

Reply: Expression of oestrogen receptor beta proteins in human breast cancer biopsies.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 688, doi. 10.1038/sj.bjc.6600535

By:

Saunders, P T K;
Miller, W R

Publication type:

Article

Biological activity of the thyroid TRK-T3 oncogene requires signalling through Shc.

Published in:

British Journal of Cancer, 2002, v. 87, n. 6, p. 645, doi. 10.1038/sj.bjc.6600544

By:

Roccato, E;
Miranda, C;
Ranzi, V;
Gishizki, M;
Pierotti, M A;
Greco, A

Publication type:

Article